Literature DB >> 8416150

The epidemiology of thyroid carcinoma.

S Franceschi1, P Boyle, P Maisonneuve, C La Vecchia, A D Burt, D J Kerr, G J MacFarlane.   

Abstract

Thyroid cancer is one of the rarest forms of cancer, yet there are wide variations in the degree of malignancy, ranging from the most rapidly fatal to the relatively benign. This is almost entirely dependent on the histological type. Generally speaking, data available on changing trends of incidence and mortality are subject to reservation, dependent on the degree to which they have been influenced by changing diagnostic criteria and the precision of histopathological description. Nevertheless, there is evidence that mortality is slowly decreasing, while incidence is slowly increasing. The purpose of this review is to try to interpret the temporal trends of incidence and mortality rates for thyroid carcinoma in the last 3 decades in light of the problems arising from changes in diagnostic standards and histological classification regarding thyroid neoplasms. Attention is also drawn to the implications, from a public health viewpoint, of the present intensive detection and treatment of occult thyroid carcinomas.

Entities:  

Mesh:

Year:  1993        PMID: 8416150

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  18 in total

1.  Thyroid cancer incidence in Ukraine: trends with reference to the Chernobyl accident.

Authors:  M Fuzik; A Prysyazhnyuk; Y Shibata; A Romanenko; Z Fedorenko; L Gulak; Y Goroh; N Gudzenko; N Trotsyuk; O Khukhrianska; V Saenko; S Yamashita
Journal:  Radiat Environ Biophys       Date:  2010-11-10       Impact factor: 1.925

Review 2.  Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis.

Authors:  Leslie R Rowe; Brandon G Bentz; Joel S Bentz
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

3.  A rare association between malignant mediastinal seminoma and other malignant neoplasms.

Authors:  M Appetecchia; E Pucci
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  Causal associations of autoimmune thyroiditis and papillary thyroid carcinoma: mRNA expression of selected nuclear receptors and other molecular targets.

Authors:  Dana Macejova; Jan Podoba; Lucia Toporova; Marianna Grigerova; Karol Kajo; Katarina Machalekova; Julius Brtko
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

5.  A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004.

Authors:  Cairong Zhu; Tongzhang Zheng; Briseis A Kilfoy; Xuesong Han; Shuangge Ma; Yue Ba; Yana Bai; Rong Wang; Yong Zhu; Yawei Zhang
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

6.  Small-Sized Thyroid Cancers-a Single Institutional Experience in India.

Authors:  U S Vishal Rao; Shrinidhi Koya; Sowjanya Gandla; Sataksi Chatterjee; Ashutosh A Patil; Ravi C Nayar; Kumar Kallur
Journal:  Indian J Surg Oncol       Date:  2017-06-29

7.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

Review 8.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

9.  Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure.

Authors:  Wei Li Cindy Ho; Margaret R Zacharin
Journal:  Eur J Pediatr       Date:  2016-01-25       Impact factor: 3.183

10.  Thyroid B-flow twinkling sign: a new feature of papillary cancer.

Authors:  Luca Brunese; Antonio Romeo; Sergio Iorio; Giuseppina Napolitano; Stefano Fucili; Pio Zeppa; Gianfranco Vallone; Gaetano Lombardi; Antonio Bellastella; Bernadette Biondi; Antonio Sodano
Journal:  Eur J Endocrinol       Date:  2008-07-21       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.